Mangoceuticals MGRX Balance Sheet (2022-2026)

NASDAQ MGRX
$0.41 +0.02 (+5.13%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Mangoceuticals Quarterly Balance Sheet

Periods 15 quarters
Latest Jun 2026

Mangoceuticals reported total assets of $14.17M and total liabilities of $1.65M for the quarter ended Jun 2026, down 32.0% year over year. This balance sheet covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 3.79M2.95M1.24M0.74M0.02M0.49M0.07M0.06M0.08M0.10M0.48M1.49M0.17M0.23M
Short-term InvestmentsInvestments (Current) 0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.02M0.02M
Cash & Current Investments 3.79M2.95M1.24M0.76M0.02M0.49M0.09M0.08M0.09M0.12M0.50M1.52M0.19M0.25M
Receivables - OtherOther Receivables 0.02M0.02M
Inventory 0.02M0.02M0.02M0.01M0.01M0.01M-0.02M
Prepaid Assets 0.06M0.01M0.08M0.10M0.01M897.0042.00
Current Assets 0.69M3.82M3.02M1.34M0.84M0.09M0.52M0.10M0.08M0.18M0.12M0.60M1.55M0.21M0.25M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.12M0.11M0.11M0.10M0.10M0.09M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Intangibles 14.61M14.61M15.23M21.53M20.69M15.92M14.23M13.94M13.65M
Goodwill & Intangibles 14.61M14.61M15.23M21.53M20.69M15.92M14.23M13.94M13.65M
Other Non-Current Assets 0.19M0.18M0.16M0.15M0.02M0.12M0.02M0.02M0.02M0.02M0.02M0.02M
Non-Current Assets 0.31M0.29M0.27M0.25M0.22M0.21M14.72M14.69M15.29M21.58M20.72M15.93M14.54M14.24M13.93M
Assets 1.00M4.12M3.30M1.60M1.05M0.30M15.24M14.79M15.37M21.75M20.84M16.53M16.09M14.45M14.17M
Liabilities
Current Liabilities
Accounts Payables 0.03M0.03M0.13M0.09M0.14M1.02M0.72M0.71M0.84M1.18M0.77M0.53M0.42M0.53M0.89M
Notes Payables 0.09M0.09M0.19M0.19M0.15M0.50M0.10M0.04M
Payables 0.12M0.03M0.13M0.09M0.14M1.10M0.91M0.90M0.99M1.18M1.27M0.63M0.42M0.53M0.93M
Accumulated Expenses 0.00M0.00M0.01M0.01M0.01M0.01M0.00M0.01M0.00M0.00M0.01M0.00M0.01M
Other Accumulated Expenses 0.40M0.38M0.37M0.25M0.16M0.16M0.16M0.15M0.15M
Current Leases 0.06M0.06M0.06M0.06M0.06M0.07M0.07M0.07M0.06M0.05M0.03M0.01M0.31M0.06M0.03M
Total Current Liabilities 0.26M0.18M0.20M0.16M0.21M1.21M1.38M1.39M1.43M1.50M1.60M0.80M0.89M0.74M1.40M
Non-Current Liabilities
Non-Current Debt 0.08M0.04M
Minority Interest -36.00-376.00-837.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Operating Leases 0.19M0.17M0.16M0.14M0.06M0.11M0.10M0.08M0.06M0.05M0.03M0.29M0.31M0.24M0.28M
Total Non-Current Liabilities 0.13M0.11M0.10M0.08M0.06M0.05M0.03M0.01M0.24M0.25M
Total Liabilities 0.39M0.30M0.29M0.24M0.28M1.26M1.41M1.40M1.43M1.50M1.60M0.80M0.89M0.97M1.65M
Shareholder's Equity
Total Debt 0.17M0.09M0.19M0.19M0.15M0.50M0.10M0.09M
Common Equity 0.61M3.82M3.00M1.35M0.77M-0.96M13.83M13.83M13.95M20.25M19.24M15.73M15.20M13.47M12.53M
Liabilities and Shareholders Equity 1.00M4.12M3.30M1.60M1.05M0.30M15.24M14.79M15.37M21.75M20.84M16.53M16.09M14.45M14.17M
Retained Earnings 2.63M8.39M9.86M10.01M12.00M-13.60M30.30M31.59M34.79M45.87M50.79M53.28M55.52M57.20M57.57M
Preferred Shares 98.0098.0098.0098.0098.0098.0098.0098.0098.00